Company Filing History:
2 out of 314 
2 out of 121 
Years Active: 1991-1993
Title: The Innovative Contributions of Chuzo Iwata
Introduction
Chuzo Iwata, an accomplished inventor based in Settsu, Japan, has made significant strides in the field of pharmaceuticals. With two patents to his name, Iwata has focused his research on compounds that have shown promising therapeutic applications, particularly in the areas of thromboxane A2 antagonism and lipid peroxidation inhibition.
Latest Patents
Iwata's latest innovations include the development of sulfonamide derivatives, which are characterized by their thromboxane A2 antagonism, making them potentially effective as blood platelet aggregation inhibiting agents. The specific molecular structure of this derivative is represented by the formula detailed in the patent specification.
Another notable patent is for 3,5-diamino-1,2,4-triazole derivatives. This triazole derivative, as described in the corresponding patent, has shown utility as an inhibitor of lipid peroxidation. The precise structure also reflects a diverse range of substituents which enhance its potential applications.
Career Highlights
Throughout his career, Iwata has been associated with reputable companies such as Taisho Pharmaceutical Co., Ltd. and Nippon Suisan Kaisha, Ltd. His work in these organizations has played a critical role in advancing pharmaceutical innovations that benefit public health.
Collaborations
Iwata has collaborated with notable colleagues, including Masakazu Sato and Yutaka Kawashima. Together, they have contributed to the body of research that underscores the importance of innovative compounds in medical treatments.
Conclusion
Chuzo Iwata’s dedication to pharmaceutical innovation illustrates the profound impact inventors can have in improving healthcare outcomes. His patented developments not only highlight his ingenuity but also serve as a foundation for future research and therapeutic advances.